NO921012L - Farmasoeytiske preparater og deres anvendelse - Google Patents

Farmasoeytiske preparater og deres anvendelse

Info

Publication number
NO921012L
NO921012L NO92921012A NO921012A NO921012L NO 921012 L NO921012 L NO 921012L NO 92921012 A NO92921012 A NO 92921012A NO 921012 A NO921012 A NO 921012A NO 921012 L NO921012 L NO 921012L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
NO92921012A
Other languages
English (en)
Other versions
NO310754B1 (no
NO921012D0 (no
Inventor
John Morley
Andreas Rummelt
Martin List
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO921012D0 publication Critical patent/NO921012D0/no
Publication of NO921012L publication Critical patent/NO921012L/no
Publication of NO310754B1 publication Critical patent/NO310754B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19921012A 1991-03-18 1992-03-16 Anvendelse av CY-A/X-III for pulmonal administrasjon samt farmasöytisk preparat omfattende CY-A/X-III NO310754B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919105705A GB9105705D0 (en) 1991-03-18 1991-03-18 Improvements in or relating to organic compounds

Publications (3)

Publication Number Publication Date
NO921012D0 NO921012D0 (no) 1992-03-16
NO921012L true NO921012L (no) 1992-09-21
NO310754B1 NO310754B1 (no) 2001-08-27

Family

ID=10691762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19921012A NO310754B1 (no) 1991-03-18 1992-03-16 Anvendelse av CY-A/X-III for pulmonal administrasjon samt farmasöytisk preparat omfattende CY-A/X-III

Country Status (29)

Country Link
US (1) US5719123A (no)
EP (1) EP0504760B1 (no)
JP (1) JP2549794B2 (no)
KR (1) KR920017644A (no)
AT (1) AT404553B (no)
AU (1) AU658172B2 (no)
CA (1) CA2063106C (no)
CH (1) CH685229A5 (no)
CZ (1) CZ281260B6 (no)
DE (1) DE4208258B4 (no)
DK (1) DK0504760T3 (no)
ES (1) ES2093130T3 (no)
FI (1) FI921125A (no)
FR (1) FR2674249A1 (no)
GB (2) GB9105705D0 (no)
GR (1) GR3021497T3 (no)
HU (1) HU208492B (no)
IE (1) IE67627B1 (no)
IL (1) IL101244A (no)
IT (1) IT1255040B (no)
LU (1) LU88087A1 (no)
MX (1) MX9201141A (no)
NO (1) NO310754B1 (no)
NZ (1) NZ241975A (no)
RU (1) RU2098122C1 (no)
SA (1) SA92120536B1 (no)
SK (1) SK279576B6 (no)
TW (1) TW215901B (no)
ZA (1) ZA921987B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837677B2 (ja) * 1981-01-13 1983-08-17 松下電器産業株式会社 誘導加熱調理器
JPH07111905B2 (ja) * 1987-07-23 1995-11-29 株式会社東芝 誘導加熱調理器の負荷適否検知回路
CA2115065C (en) * 1992-06-12 2000-10-03 Kiyoyuki Sakon Ultrafine particle powder for inhalation and method for production thereof
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
TW581681B (en) * 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
FI20002217A (fi) * 1999-12-30 2001-07-01 Orion Yhtymae Oyj Inhalaatiopartikkelit
FI20010115A0 (fi) * 2001-01-18 2001-01-18 Orion Corp Menetelmä nanopartikkelien valmistamiseksi
AR036852A1 (es) * 2001-10-19 2004-10-06 Isotechnika Inc Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
EP1610878B1 (en) * 2003-02-21 2014-09-03 University Of Bath Process for the production of particles
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
WO2006124047A2 (en) * 2004-08-13 2006-11-23 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070124218A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions
EP2714720B1 (en) * 2011-05-27 2018-12-26 Allergan, Inc. A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
JO3410B1 (ar) 2011-06-07 2019-10-20 Otsuka Pharma Co Ltd تركيبة أريبيبرازول مجفف بالتبريد
WO2013074608A1 (en) * 2011-11-15 2013-05-23 Allergan, Inc. Cyclosporine a form 2 and method of making same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
CH679119A5 (no) * 1988-05-13 1991-12-31 Sandoz Ag
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
AU1294092A (en) 1992-09-24
DK0504760T3 (da) 1996-12-23
TW215901B (no) 1993-11-11
DE4208258A1 (de) 1992-09-24
CA2063106A1 (en) 1992-09-19
NO310754B1 (no) 2001-08-27
SK279576B6 (sk) 1999-01-11
ZA921987B (en) 1993-09-20
CH685229A5 (de) 1995-05-15
IL101244A0 (en) 1992-11-15
FI921125A0 (fi) 1992-03-16
IE67627B1 (en) 1996-04-17
EP0504760A1 (en) 1992-09-23
MX9201141A (es) 1992-10-01
ES2093130T3 (es) 1996-12-16
FR2674249A1 (fr) 1992-09-25
DE4208258B4 (de) 2007-07-12
EP0504760B1 (en) 1996-10-09
HU9200735D0 (en) 1992-05-28
GB9105705D0 (en) 1991-05-01
KR920017644A (ko) 1992-10-21
NZ241975A (en) 1994-04-27
IL101244A (en) 1996-10-31
FI921125A (fi) 1992-09-19
ITRM920181A0 (it) 1992-03-17
CS78592A3 (en) 1992-10-14
IT1255040B (it) 1995-10-13
GB2253853A (en) 1992-09-23
FR2674249B1 (no) 1995-05-12
LU88087A1 (fr) 1993-10-27
GR3021497T3 (en) 1997-01-31
JP2549794B2 (ja) 1996-10-30
HU208492B (en) 1993-11-29
ATA53492A (de) 1998-05-15
CZ281260B6 (cs) 1996-07-17
NO921012D0 (no) 1992-03-16
GB2253853B (en) 1995-04-26
IE920839A1 (en) 1992-09-23
AT404553B (de) 1998-12-28
RU2098122C1 (ru) 1997-12-10
SA92120536B1 (ar) 2005-04-27
ITRM920181A1 (it) 1993-09-17
AU658172B2 (en) 1995-04-06
HUT61324A (en) 1992-12-28
US5719123A (en) 1998-02-17
GB9205554D0 (en) 1992-04-29
CA2063106C (en) 2002-12-17
JPH0585940A (ja) 1993-04-06

Similar Documents

Publication Publication Date Title
NO921012L (no) Farmasoeytiske preparater og deres anvendelse
NO943511L (no) Farmasöytiske preparater og anvendelse derav
DK1023900T3 (da) Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
NO893678D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO922506D0 (no) Farmasoeytiske preparat
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
NO924060D0 (no) Peg-imidater og proteinderivater derav
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
DK0540609T3 (da) Cephalosporiner og homologer, fremstillinger og farmaceutiske præparater
DK0455396T3 (da) Vandige gelpræparater og deres anvendelse.
DK130389A (da) Catecholderivater og farmaceutiske praeparater omfatende samme
DK162491D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK4491A (da) Aclonifen-baserede herbicidblandinger og deres anvendelse
DK0579741T3 (da) Insekticidt præparat og insekticide enheder
DK246189A (da) Antimikrobielt praeparat og anvendelse deraf
DK650089A (da) Furanalkylketoner og farmaceutiske praeparater deraf
DK634089A (da) Polyhydroxybenzyloxypropanolaminer og deres anvendelse
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
NO921049L (no) Bakterieinhiberende preparat og anvendelse derav
NO920564L (no) Farmasoeytiske adenosinholdige preparater
NO941426D0 (no) Antisporiatiske farmasöytiske preparater og fremgangsmåte for fremstilling av slike
NO920228L (no) Polylaktider, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
MK1K Patent expired